Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

The COVID-19 Pandemic: Fears and Overprotection in Pediatric Patients with Inflammatory Bowel Disease and Their Families

  • Received : 2020.09.15
  • Accepted : 2020.12.26
  • Published : 2021.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The coronavirus disease 2019 (COVID-19) pandemic has influenced the lives of people worldwide. Little is known about the effects of the COVID-19 pandemic on the behavior and fears of pediatric patients with inflammatory bowel disease (IBD) and their families. We conducted a survey to determine the COVID-19 exposure, related perceptions, and information sources; medication compliance; and patients' and parents' behaviors, fears, and physician contact. Methods: An anonymous cross-sectional survey of pediatric patients with IBD and their parents at one pediatric gastroenterology unit of a university medical center was performed. Results: A total of 46 pediatric patients with IBD and 44 parents completed the survey. Parents of pediatric patients with IBD had high fear of their children becoming infected with severe acute respiratory syndrome coronavirus 2. They perceived schools as the most hazardous environment, whereas the children did not. Half the pediatric patients with IBD feared infection. Patients and parents felt sufficiently informed about COVID-19. The primary source of guidance for pediatric patients was their parents (43%), followed by television and social media, whereas the parents mainly consulted internet news websites (52.2%), television, and public health institutes. Pediatric patients with IBD adhered to their prescribed medication. They also showed cautious behavior by enhancing hand hygiene (84%) and leaving the house less frequently than before. However, in-person medical visits remained favored over video consultations. Conclusion: Although parents expressed overprotective concerns, both parents and pediatric patients with IBD are coping well with the COVID-19 pandemic. IBD-relevant information should be actively conveyed.

Keywords

References

  1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. https://doi.org/10.1016/s0140-6736(20)30566-3
  2. Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database Syst Rev 2020;7:CD013665.
  3. Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F, et al. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur Respir J 2020;56:2001634. https://doi.org/10.1183/13993003.01634-2020
  4. Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ 2020;368:m1198. https://doi.org/10.1136/bmj.m1198
  5. Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020;39:355-68. https://doi.org/10.1097/INF.0000000000002660
  6. Monteleone G, Ardizzone S. Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? J Crohn's Colitis 2020;14:1334-6. https://doi.org/10.1093/ecco-jcc/jjaa061
  7. Neurath MF. COVID-19 and immunomodulation in IBD. Gut 2020;69:1335-42. https://doi.org/10.1136/gutjnl-2020-321269
  8. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJHLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033-4. https://doi.org/10.1016/s0140-6736(20)30628-0
  9. Weible CM, Nohrstedt D, Cairney P, Carter DP, Crow DA, Durnova AP, et al. COVID-19 and the policy sciences: initial reactions and perspectives. Policy Sci 2020. [doi: 10.1007/s11077-020-09381-4. [Epub ahead of print].
  10. The Centers for Medicare & Medicaid Services (CMS). CMS releases recommendations on adult elective surgeries, non-essential medical, surgical, and dental procedures during COVID-19 response [Internet]. Baltimore (MD): CMS; 2020 Mar 18 [cited 2020 Apr 23]. Available from: https://www.cms.gov/newsroom/ press-releases/cms-releases-recommendations-adult-elective-surgeries-non-essential-medical-surgicaland-dental
  11. World Health Organization (WHO). Coronavirus disease (COVID-19) advice for the public [Internet]. Geneva: WHO; 2020 [cited 2020 Apr 22]. Available from: https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/advice-for-public
  12. Reuken PA, Rauchfuss F, Albers S, Settmacher U, Trautwein C, Bruns T, et al. Between fear and courage: attitudes, beliefs, and behavior of liver transplantation recipients and waiting list candidates during the COVID-19 pandemic. Am J Transplant 2020;20:3042-50. https://doi.org/10.1111/ajt.16118
  13. Grunert PC, Reuken PA, Stallhofer J, Teich N, Stallmach A. Inflammatory bowel disease in the COVID-19 pandemic - the patients' perspective. J Crohn's Colitis 2020. doi: 10.1093/ecco-jcc/jjaa126. [Epub ahead of print].
  14. D'Amico F, Rahier JF, Leone S, Peyrin-Biroulet L, Danese S. Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey. Lancet Gastroenterol Hepatol 2020;5:631-2. https://doi.org/10.1016/S2468-1253(20)30151-5
  15. Casanova M, Pagani Bagliacca E, Silva M, Patriarca C, Veneroni L, Clerici CA, et al. How young patients with cancer perceive the COVID-19 (coronavirus) epidemic in Milan, Italy: is there room for other fears? Pediatr Blood Cancer 2020;67:e28318. https://doi.org/10.1002/pbc.28318
  16. Choi SH, Kim HW, Kang JM, Kim DH, Cho EY. Epidemiology and clinical features of coronavirus disease 2019 in children. Clin Exp Pediatr 2020;63:125-32. https://doi.org/10.3345/cep.2020.00535
  17. Lassandro G, Palladino V, Amoruso A, Palmieri VV, Russo G, Giordano P. Children in coronaviruses' wonderland: what clinicians need to know. Mediterr J Hematol Infect Dis 2020;12:e2020042. https://doi.org/10.4084/mjhid.2020.042
  18. MacPhee M, Hoffenberg EJ, Feranchak A. Quality-of-life factors in adolescent inflammatory bowel disease. Inflamm Bowel Dis 1998;4:6-11. https://doi.org/10.1097/00054725-199802000-00002
  19. Brydolf M, Segesten K. Living with ulcerative colitis: experiences of adolescents and young adults. J Adv Nurs 1996;23:39-47. https://doi.org/10.1111/j.1365-2648.1996.tb03133.x
  20. Mackner LM, Sisson DP, Crandall WV. Review: psychosocial issues in pediatric inflammatory bowel disease. J Pediatr Psychol 2004;29:243-57. https://doi.org/10.1093/jpepsy/jsh027
  21. Brenner EJ, Ungaro RC, Colombel JF, Kappelman MD. SECURE-IBD Database public data update [Internet]. City: SECURE-IBD; 2020 [cited 2020 Aug 20]. Available from: https://covidibd.org/current-data/
  22. Sprang G, Silman M. Posttraumatic stress disorder in parents and youth after health-related disasters. Disaster Med Public Health Prep 2013;7:105-10. https://doi.org/10.1017/dmp.2013.22
  23. Ghosh R, Dubey MJ, Chatterjee S, Dubey S. Impact of COVID -19 on children: special focus on the psychosocial aspect. Minerva Pediatr 2020;72:226-35.

Cited by

  1. Prevalence and Course of SARS-CoV-2 Infection among Immunocompromised Children Hospitalised in the Tertiary Referral Hospital in Poland vol.10, pp.19, 2021, https://doi.org/10.3390/jcm10194556
  2. Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment vol.27, pp.46, 2021, https://doi.org/10.3748/wjg.v27.i46.7943